Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 22nd Century Group Inc XXII

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco... see more

Recent & Breaking News (NDAQ:XXII)

Phase III Clinical Trial with 22nd Century’s Very Low Nicotine Cigarettes Names Ten Major Research Institutions as Study Locations

Business Wire October 6, 2016

22nd Century Announces Expiration of 2,250,000 Crede Warrants

Business Wire October 4, 2016

Overwhelming Physician and Consumer Support Cited for 22nd Century’s “X-22” Very Low Nicotine Smoking Cessation Product

Business Wire September 27, 2016

22nd Century Group to Present at The MicroCap Conference on October 24-25 in Philadelphia

Accesswire September 21, 2016

22nd Century Announces Expansion of Cannabis Research Program

Business Wire September 6, 2016

Research Report Initiation on Biotech Stocks -- PTC Therapeutics, Grifols, Puma Biotech, and 22nd Century

PR Newswire August 22, 2016

22nd Century Group Files 2016 Second Quarter Report Announces Conference Call to Provide Business Update

Business Wire August 9, 2016

22nd Century Group Alleviates Near-Term Financing Risk After Raising $5 Million In Capital

Benzinga.com  July 26, 2016

22nd Century Group Announces $5.0 Million Registered Direct Offering at Market

Business Wire July 25, 2016

Nicotine Reduction Strategy is Championed by Growing Number of Scientists and Public Health Experts

Business Wire July 14, 2016

World Health Organization Recommends “Mandated Reductions in Nicotine to Minimally Addictive Levels”

Business Wire July 11, 2016

22nd Century’s Very Low Nicotine Cigarettes Reduce Smoking and Are Now Associated with Reduced Alcohol Use

Business Wire June 28, 2016

New Study Shows Cigarettes Containing 22nd Century’s Proprietary Tobacco Reduce Smoking and Toxicant Exposure

Business Wire June 22, 2016

22nd Century’s Proprietary SPECTRUM® Cigarettes Identified as Crucial Tool in Human Addiction Studies

Business Wire June 16, 2016

Demand Continues to Surge for Cannabis & Industrial Hemp Products While Becoming a Cornerstone for Financial Stability for Growers & Processing Facilities

PR Newswire June 7, 2016

Cannabis & Legal Marijuana Sector Continues To See Steady Growth As Companies Launch Newest Innovative Products; Company to Develop First Ever MMJ Plant to Paper Product

PR Newswire June 1, 2016

22nd Century Presents at Hofstra Northwell School of Medicine; Reveals New Initiative to Engage Health Care Professionals

Business Wire May 27, 2016

22nd Century Launches MAGIC 0 Very Low Nicotine Cigarettes in France

Business Wire May 25, 2016

22nd Century lance les cigarettes MAGIC 0 à très faible teneur en nicotine en France

Business Wire May 25, 2016

Independent Phase II and III Clinical Studies on 22nd Century's Smoking Cessation Technology Highlighted on New Heracles Website

Business Wire May 24, 2016